0001209191-19-059363.txt : 20191205 0001209191-19-059363.hdr.sgml : 20191205 20191205181354 ACCESSION NUMBER: 0001209191-19-059363 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191203 FILED AS OF DATE: 20191205 DATE AS OF CHANGE: 20191205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guyer Shelly D CENTRAL INDEX KEY: 0001588984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38853 FILM NUMBER: 191271343 MAIL ADDRESS: STREET 1: 1025 GREEN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94133 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001426332 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-243-5555 MAIL ADDRESS: STREET 1: 333 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-03 0 0001426332 NGM BIOPHARMACEUTICALS INC NGM 0001588984 Guyer Shelly D 1400 16TH STREET SAN FRANCISCO CA 94103 1 0 0 0 Stock Option (Right to Buy) 17.24 2019-12-03 4 A 0 48355 17.24 A 2029-12-02 Common Stock 48355 48355 D The shares subject to the stock option are early exercisable and vest over a three-year period, with 1/3rd of the shares vested on December 3, 2020, and the remainder vesting in eight (8) equal quarterly installments measured from December 3, 2020. /s/ Valerie Pierce, Attorney-in-Fact 2019-12-05